Cargando…
P1675: SUTIMLIMAB PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: OPEN-LABEL EXTENSION OF THE PHASE 3 CADENZA STUDY
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430149/ http://dx.doi.org/10.1097/01.HS9.0000973572.71532.1f |
| _version_ | 1785090886656327680 |
|---|---|
| author | Röth, Alexander Broome, Catherine M Barcellini, Wilma Jilma, Bernd Hill, Quentin A Cella, David Tvedt, Tor Henrik Anderson Yamaguchi, Masaki Murakhovskaya, Irina Lee, Michelle Shafer, Frank Wardęcki, Marek Jayawardene, Deepthi Yoo, Ronnie Msihid, Jerome Weitz, Ilene C |
| author_facet | Röth, Alexander Broome, Catherine M Barcellini, Wilma Jilma, Bernd Hill, Quentin A Cella, David Tvedt, Tor Henrik Anderson Yamaguchi, Masaki Murakhovskaya, Irina Lee, Michelle Shafer, Frank Wardęcki, Marek Jayawardene, Deepthi Yoo, Ronnie Msihid, Jerome Weitz, Ilene C |
| author_sort | Röth, Alexander |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430149 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104301492023-08-17 P1675: SUTIMLIMAB PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: OPEN-LABEL EXTENSION OF THE PHASE 3 CADENZA STUDY Röth, Alexander Broome, Catherine M Barcellini, Wilma Jilma, Bernd Hill, Quentin A Cella, David Tvedt, Tor Henrik Anderson Yamaguchi, Masaki Murakhovskaya, Irina Lee, Michelle Shafer, Frank Wardęcki, Marek Jayawardene, Deepthi Yoo, Ronnie Msihid, Jerome Weitz, Ilene C Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430149/ http://dx.doi.org/10.1097/01.HS9.0000973572.71532.1f Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Röth, Alexander Broome, Catherine M Barcellini, Wilma Jilma, Bernd Hill, Quentin A Cella, David Tvedt, Tor Henrik Anderson Yamaguchi, Masaki Murakhovskaya, Irina Lee, Michelle Shafer, Frank Wardęcki, Marek Jayawardene, Deepthi Yoo, Ronnie Msihid, Jerome Weitz, Ilene C P1675: SUTIMLIMAB PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: OPEN-LABEL EXTENSION OF THE PHASE 3 CADENZA STUDY |
| title | P1675: SUTIMLIMAB PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: OPEN-LABEL EXTENSION OF THE PHASE 3 CADENZA STUDY |
| title_full | P1675: SUTIMLIMAB PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: OPEN-LABEL EXTENSION OF THE PHASE 3 CADENZA STUDY |
| title_fullStr | P1675: SUTIMLIMAB PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: OPEN-LABEL EXTENSION OF THE PHASE 3 CADENZA STUDY |
| title_full_unstemmed | P1675: SUTIMLIMAB PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: OPEN-LABEL EXTENSION OF THE PHASE 3 CADENZA STUDY |
| title_short | P1675: SUTIMLIMAB PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: OPEN-LABEL EXTENSION OF THE PHASE 3 CADENZA STUDY |
| title_sort | p1675: sutimlimab provides sustained improvements in patient-reported outcomes and quality of life in patients with cold agglutinin disease: open-label extension of the phase 3 cadenza study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430149/ http://dx.doi.org/10.1097/01.HS9.0000973572.71532.1f |
| work_keys_str_mv | AT rothalexander p1675sutimlimabprovidessustainedimprovementsinpatientreportedoutcomesandqualityoflifeinpatientswithcoldagglutinindiseaseopenlabelextensionofthephase3cadenzastudy AT broomecatherinem p1675sutimlimabprovidessustainedimprovementsinpatientreportedoutcomesandqualityoflifeinpatientswithcoldagglutinindiseaseopenlabelextensionofthephase3cadenzastudy AT barcelliniwilma p1675sutimlimabprovidessustainedimprovementsinpatientreportedoutcomesandqualityoflifeinpatientswithcoldagglutinindiseaseopenlabelextensionofthephase3cadenzastudy AT jilmabernd p1675sutimlimabprovidessustainedimprovementsinpatientreportedoutcomesandqualityoflifeinpatientswithcoldagglutinindiseaseopenlabelextensionofthephase3cadenzastudy AT hillquentina p1675sutimlimabprovidessustainedimprovementsinpatientreportedoutcomesandqualityoflifeinpatientswithcoldagglutinindiseaseopenlabelextensionofthephase3cadenzastudy AT celladavid p1675sutimlimabprovidessustainedimprovementsinpatientreportedoutcomesandqualityoflifeinpatientswithcoldagglutinindiseaseopenlabelextensionofthephase3cadenzastudy AT tvedttorhenrikanderson p1675sutimlimabprovidessustainedimprovementsinpatientreportedoutcomesandqualityoflifeinpatientswithcoldagglutinindiseaseopenlabelextensionofthephase3cadenzastudy AT yamaguchimasaki p1675sutimlimabprovidessustainedimprovementsinpatientreportedoutcomesandqualityoflifeinpatientswithcoldagglutinindiseaseopenlabelextensionofthephase3cadenzastudy AT murakhovskayairina p1675sutimlimabprovidessustainedimprovementsinpatientreportedoutcomesandqualityoflifeinpatientswithcoldagglutinindiseaseopenlabelextensionofthephase3cadenzastudy AT leemichelle p1675sutimlimabprovidessustainedimprovementsinpatientreportedoutcomesandqualityoflifeinpatientswithcoldagglutinindiseaseopenlabelextensionofthephase3cadenzastudy AT shaferfrank p1675sutimlimabprovidessustainedimprovementsinpatientreportedoutcomesandqualityoflifeinpatientswithcoldagglutinindiseaseopenlabelextensionofthephase3cadenzastudy AT wardeckimarek p1675sutimlimabprovidessustainedimprovementsinpatientreportedoutcomesandqualityoflifeinpatientswithcoldagglutinindiseaseopenlabelextensionofthephase3cadenzastudy AT jayawardenedeepthi p1675sutimlimabprovidessustainedimprovementsinpatientreportedoutcomesandqualityoflifeinpatientswithcoldagglutinindiseaseopenlabelextensionofthephase3cadenzastudy AT yooronnie p1675sutimlimabprovidessustainedimprovementsinpatientreportedoutcomesandqualityoflifeinpatientswithcoldagglutinindiseaseopenlabelextensionofthephase3cadenzastudy AT msihidjerome p1675sutimlimabprovidessustainedimprovementsinpatientreportedoutcomesandqualityoflifeinpatientswithcoldagglutinindiseaseopenlabelextensionofthephase3cadenzastudy AT weitzilenec p1675sutimlimabprovidessustainedimprovementsinpatientreportedoutcomesandqualityoflifeinpatientswithcoldagglutinindiseaseopenlabelextensionofthephase3cadenzastudy |